GAO Won't Revisit View On Late Electronic Bids In FDA Case
The U.S. Government Accountability Office has refused to reconsider its precedent for when electronic bid submissions are considered late, saying the U.S. Food and Drug Administration reasonably found a contract proposal...To view the full article, register now.
Already a subscriber? Click here to view full article